National Medical Care Company
TADAWUL:4005.SR
202.2 (SAR) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,081.783 | 917.935 | 845.381 | 808.953 | 708.394 | 763.804 | 855.084 | 900.654 | 878.667 | 733.995 | 586.276 | 524.749 | 458.285 | 426.219 | 374.46 |
| Cost of Revenue
| 726.829 | 628.254 | 598.911 | 585.072 | 542.738 | 597.294 | 659.681 | 696.09 | 658.463 | 589.017 | 462.469 | 389.614 | 335.84 | 322.911 | 298.274 |
| Gross Profit
| 354.955 | 289.681 | 246.469 | 223.881 | 165.656 | 166.51 | 195.402 | 204.564 | 220.204 | 144.978 | 123.807 | 135.135 | 122.444 | 103.308 | 76.186 |
| Gross Profit Ratio
| 0.328 | 0.316 | 0.292 | 0.277 | 0.234 | 0.218 | 0.229 | 0.227 | 0.251 | 0.198 | 0.211 | 0.258 | 0.267 | 0.242 | 0.203 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 41.379 | 21.848 | 18.991 | 16.905 | 14.729 | 15.809 | 105.048 | 122.648 | 84.318 | 77.629 | 34.471 | 29.522 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 8.527 | 4.465 | 11.984 | 42.36 | 0.593 | 0.489 | 0.388 | 0.525 | 1.815 | 1.879 | 3.424 | 0.985 | 0 | 0 | 0 |
| SG&A
| 112.26 | 26.314 | 30.975 | 59.264 | 15.323 | 16.298 | 105.436 | 109.203 | 76.284 | 80.506 | 37.894 | 30.507 | 0 | 0 | 0 |
| Other Expenses
| 0.634 | 65.954 | 59.279 | 50.504 | 60.693 | 7.742 | 13.806 | -125.855 | -91.516 | -54.212 | -32.256 | -31.126 | -27.263 | -21.742 | -20.994 |
| Operating Expenses
| 112.26 | 92.268 | 90.253 | 109.768 | 76.016 | 86.583 | 105.436 | -125.855 | -91.516 | -54.212 | -32.256 | -31.126 | -27.263 | -21.742 | -20.994 |
| Operating Income
| 242.695 | 197.413 | 155.285 | 114.113 | 104.838 | 88.426 | 103.773 | 78.709 | 128.689 | 90.766 | 91.551 | 104.009 | 95.182 | 81.566 | 55.192 |
| Operating Income Ratio
| 0.224 | 0.215 | 0.184 | 0.141 | 0.148 | 0.116 | 0.121 | 0.087 | 0.146 | 0.124 | 0.156 | 0.198 | 0.208 | 0.191 | 0.147 |
| Total Other Income Expenses Net
| 21.9 | 1.089 | 9.117 | 9.184 | -2.126 | 3.684 | 10.166 | -12.631 | -78.565 | -43.128 | -24.185 | -23.729 | -21.39 | -12.804 | -15.024 |
| Income Before Tax
| 264.595 | 198.502 | 164.402 | 123.297 | 102.712 | 83.611 | 100.133 | 66.078 | 141.639 | 101.85 | 99.623 | 111.406 | 101.054 | 90.504 | 61.162 |
| Income Before Tax Ratio
| 0.245 | 0.216 | 0.194 | 0.152 | 0.145 | 0.109 | 0.117 | 0.073 | 0.161 | 0.139 | 0.17 | 0.212 | 0.221 | 0.212 | 0.163 |
| Income Tax Expense
| 23.667 | 28.427 | 28.045 | 26.028 | 22.622 | 21.428 | 14.837 | 16.767 | -80.595 | -45.92 | -25.128 | -24.677 | -20.926 | -15.987 | -16.538 |
| Net Income
| 240.927 | 170.075 | 136.357 | 97.269 | 80.09 | 62.182 | 85.296 | 49.311 | 130.718 | 93.558 | 92.495 | 104.957 | 94.718 | 84.75 | 56.706 |
| Net Income Ratio
| 0.223 | 0.185 | 0.161 | 0.12 | 0.113 | 0.081 | 0.1 | 0.055 | 0.149 | 0.127 | 0.158 | 0.2 | 0.207 | 0.199 | 0.151 |
| EPS
| 5.37 | 3.79 | 3.04 | 2.17 | 1.79 | 1.39 | 1.9 | 1.12 | 2.91 | 2.13 | 2.12 | 2.76 | 2.49 | 2.22 | 1.49 |
| EPS Diluted
| 5.37 | 3.79 | 3.04 | 2.17 | 1.79 | 1.39 | 1.9 | 1.12 | 2.91 | 2.13 | 2.12 | 2.76 | 2.49 | 2.22 | 1.49 |
| EBITDA
| 297.625 | 243.094 | 206.373 | 170.315 | 173.505 | 161.308 | 172.183 | 78.709 | 220.204 | 144.978 | 123.807 | 135.135 | 122.444 | 103.308 | 76.186 |
| EBITDA Ratio
| 0.275 | 0.265 | 0.244 | 0.211 | 0.245 | 0.211 | 0.201 | 0.087 | 0.251 | 0.198 | 0.211 | 0.258 | 0.267 | 0.242 | 0.203 |